PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
28.40%
Revenue growth exceeding 1.5x VET's 13.85%. David Dodd would verify if faster growth reflects superior business model.
No Data
No Data available this quarter, please select a different quarter.
81.45%
Gross profit growth 1.25-1.5x VET's 67.87%. Bruce Berkowitz would examine sustainability.
41.31%
Similar margin change to VET's 47.44%. Walter Schloss would investigate industry pricing power.
No Data
No Data available this quarter, please select a different quarter.
-77.70%
G&A reduction while VET shows 20.82% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-61.11%
Other expenses reduction while VET shows 85.23% growth. Joel Greenblatt would examine efficiency.
-56.24%
Operating expenses reduction while VET shows 17.54% growth. Joel Greenblatt would examine advantage.
-24.19%
Total costs reduction while VET shows 2.79% growth. Joel Greenblatt would examine advantage.
-5.15%
Interest expense reduction while VET shows 13.84% growth. Joel Greenblatt would examine advantage.
-1.23%
Both companies reducing D&A. Martin Whitman would check industry patterns.
86.08%
EBITDA growth 50-75% of VET's 156.40%. Martin Whitman would scrutinize operations.
177.48%
EBITDA margin growth while VET declines. John Neff would investigate advantages.
60.76%
Similar operating income growth to VET's 58.89%. Walter Schloss would investigate industry trends.
69.44%
Similar operating margin growth to VET's 63.90%. Walter Schloss would investigate industry trends.
5.56%
Other expenses growth while VET reduces costs. John Neff would investigate differences.
58.85%
Similar pre-tax income growth to VET's 62.71%. Walter Schloss would investigate industry trends.
67.95%
Similar pre-tax margin growth to VET's 67.24%. Walter Schloss would investigate industry trends.
28.21%
Tax expense growth less than half of VET's 107.87%. David Dodd would verify if advantage is sustainable.
59.63%
Net income growth exceeding 1.5x VET's 17.47%. David Dodd would verify competitive advantages.
68.56%
Net margin growth exceeding 1.5x VET's 27.52%. David Dodd would verify competitive advantages.
59.49%
EPS growth exceeding 1.5x VET's 18.18%. David Dodd would verify competitive advantages.
59.66%
Diluted EPS growth exceeding 1.5x VET's 18.18%. David Dodd would verify competitive advantages.
-0.28%
Share count reduction while VET shows 0.37% change. Joel Greenblatt would examine strategy.
No Data
No Data available this quarter, please select a different quarter.